Overview
Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)
Status:
Completed
Completed
Trial end date:
2011-12-01
2011-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Prospective, multicenter, double-blind, phase II, randomized, dose-response study in 5 parallel groups (dose-range).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bioprojet
Criteria
Main inclusion Criteria:- Patient with OSA (treated or not with nCPAP) and still complaining of EDS
- Epworth Sleepiness Scale score > or = to 11
Main exclusion Criteria:
- Patient suffering from chronic severe insomnia in accordance with the International
Classification of Sleep Disorders, but without OSA